Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 54, 2024 - Issue 4
84
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Synthesis and biological evaluation of amide derivatives of the quinazoline tethered (pyridyl)-1,2,4-thiadiazoles as anticancer agents

, &
Pages 305-311 | Received 09 Oct 2023, Published online: 29 Dec 2023
 

Abstract

A new library of amide derivatives of quinazoline-1, 2, 4-thiadiazoles (12a–j) has been synthesized and its structures were confirmed by 1H NMR, 13C NMR and mass spectral data. The in-vitro anticancer activity of all the newly derived compounds (12a–j) was assessed for their preliminary anticancer applications toward different cancer cell lines including MCF-7 (breast cancer), A549 (lung cancer), Colo-205 (colon cancer) and A2780 (ovarian cancer) by employing the MTT method using Etoposide as a positive control. From the table the results indicated that most of the tested compounds displayed good to moderate activity compared to etoposide. Among the twelve compounds synthesized, compounds 12a, 12b, 12c, 12d, 12e and 12f possessed more potent activity than the positive control. Particularly, compound 12a displayed superior anticancer activity.

Graphical Abstract

Acknowledgments

The authors are thankful to School of Applied Sciences, REVA University, Bangalore, Karnataka for constant encouragement during this research program for providing basic research facility.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.